A Pilot Study to Assess the Safety and Efficacy of Alefacept in de Novo Kidney Transplant Recipients.

Trial Profile

A Pilot Study to Assess the Safety and Efficacy of Alefacept in de Novo Kidney Transplant Recipients.

Discontinued
Phase of Trial: Phase I

Latest Information Update: 05 Jun 2015

At a glance

  • Drugs Alefacept (Primary) ; Alefacept (Primary)
  • Indications Renal transplant rejection
  • Focus Adverse reactions
  • Most Recent Events

    • 18 Nov 2011 Planned end date changed from 1 Dec 2011 to 1 Aug 2012 as reported by ClinicalTrials.gov.
    • 18 Nov 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 28 Apr 2011 Planned End Date changed from 1 Jun 2011 to 1 Dec 2011.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top